| Literature DB >> 28101150 |
Jing Tian1, Xinjiang An1, Mingyu Fu1, Qingwen Wang1.
Abstract
The clinical effects were compared and analyzed of traditional Chinese medicine (TCM) 'Ling Gui Long Mu soup' combined with the conventional Western medications in treating child typhoid complicated by myocarditis. From July, 2010 to May, 2014, 54 children suffering from typhoid complicated by myocarditis were enrolled in the present study. The patients were divided into the observation and control groups (n=27 cases per group) according to the random number table. Patients in the observation group were treated with basic Western medicine combined with TCM 'Ling Gui Long Mu soup' while patients in the control group were treated only with Western medicine. We analyzed the final curative effects in the two groups. The total effective rate in the observation group was significantly higher than that of the control group and the difference was statistically significant (P<0.05). The improvement rate of the syndrome in the TCM observation group was significantly higher than that in the control group and the difference was statistically significant (P<0.05). Although the C-reactive protein (CRP) and creatinine kinase-MB (CK-MB) levels in the two groups were decreased following the treatment, CRP and CK-MB levels in the observation group were further reduced, and the difference was statistically significant (P<0.05). In conclusion, for child typhoid complicated by myocarditis, TCM 'Ling Gui Long Mu soup' significantly improved the clinical efficiency of the treatment and improved the syndrome. Therefore, 'Ling Gui Long Mu soup' is useful in clinical practice.Entities:
Keywords: Ling Gui Long Mu soup; child typhoid; myocarditis; traditional Chinese medicine syndrome
Year: 2016 PMID: 28101150 PMCID: PMC5228274 DOI: 10.3892/etm.2016.3803
Source DB: PubMed Journal: Exp Ther Med ISSN: 1792-0981 Impact factor: 2.447
Comparison of the clinical efficiency in the two groups, n (%).
| Groups | Recovery, n (%) | Effective, n (%) | Ineffective, n (%) | Total efficiency, n (%) |
|---|---|---|---|---|
| Observation group (n=27) | 13 (48.1) | 12 (44.4) | 2 (7.4) | 25 (92.5) |
| Control group (n=27) | 10 (37.0) | 9 (33.3) | 8 (29.6) | 19 (70.3) |
| χ2 | 2.358 | 2.413 | 2.856 | 3.412 |
| P-value | 0.032 | 0.034 | 0.028 | 0.017 |
Comparison of the improvement rate of the syndrome in the two groups, n (%).
| Groups | Recovery, n (%) | Effective, n (%) | Ineffective, n (%) | Total efficiency, n (%) |
|---|---|---|---|---|
| Observation group (n=27) | 14 (51.9) | 10 (37.0) | 3 (11.1) | 24 (88.9) |
| Control group (n=27) | 8 (29.6) | 9 (33.3) | 10 (37.0) | 19 (62.9) |
| χ2 | 3.526 | 0.856 | 2.845 | 3.956 |
| P-value | 0.024 | 0.632 | 0.031 | <0.001 |
TCM, traditional Chinese medicine.
Comparison of changes observed in CK-MB and CRP levels in the two groups.
| Groups | CK-MB (U/l) | CRP (mg/l) | ||
|---|---|---|---|---|
| Pre-treatment | Post-treatment | Pre-treatment | Post-treatment | |
| Observation group | 89.3±12.4 | 23.5±6.8 | 12.4±3.6 | 5.8±2.1 |
| Control group | 86.5±14.6 | 45.2±5.1 | 11.2±4.3 | 7.7±1.9 |
| t-test | 0.365 | 3.625 | 0.638 | 3.417 |
| P-value | 0.204 | 0.024 | 0.412 | 0.021 |
CRP, C-reactive protein; CK-MB, creatinine kinase-MB.